What does CUSIP 60770K107 represent in this 13F holders report?

CUSIP 60770K107 is the security identifier for MRNA - Moderna, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held MRNA - Moderna, Inc. - Common Stock in Q2 2026?

775 institutional investors reported MRNA - Moderna, Inc. - Common Stock for Q2 2026. Use the holders table for investor-level position and value details.

Moderna, Inc. - Common Stock (MRNA)

CUSIP: 60770K107

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock
Total 13F shares: 318,656,671
Total 13F value: $22,295,451,794
Share change: +10,872,923
Put/Call ratio: 101%
SEC-reported price per share: $70.03
Number of holders: 775
Value change: +$822,521,305
Number of buys: 387
Number of sells: 320
Shares outstanding: 397,803,500

Security key

60770K107

Report period

Q2 2026

Institutions

775

Top holders

MRNA full security history Ownership snapshot Full 13F holder table Moderna, Inc. SEC filings Moderna, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 13F Lead comparable stake: 13% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 13%

VANGUARD CAPITAL MANAGEMENT LLC 6.5%

Capital World Investors 5.6%

BAILLIE GIFFORD & CO 4.6%

BlackRock, Inc. 7.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13D/G 13F Company 13D/G 13F	13%	$3,471,378,759 51,803,891 shares	+$703,767,298	30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC	13D/G 13F Vanguard Capital Management · Company 13D/G 13F	6.5%	$1,317,438,259 25,933,824 shares	$0	31 Mar 2026
Capital World Investors	13D/G 13F Company 13D/G 13F	5.6%	$1,492,781,502 22,276,996 shares	$0	30 Jun 2026
BAILLIE GIFFORD & CO	13D/G 13F Company 13D/G 13F	4.6%	$1,275,020,663 18,206,778 shares	-$166,232,732	30 Jun 2026
BlackRock, Inc.	13F Company 13F	7.4%	$1,505,502,493 29,635,876 shares	—	31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC	13F Company 13F	3.9%	$793,311,444 15,616,367 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

775

318,656,671

Rows available

775

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

722

Q2 2026 holders

775

Holder diff

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %